MHRA RECLASSIFIES VIAGRA CONNECT TABLETS TO A PHARMACY MEDICINE Previous item NOVEMBER 2017 PRICE... Next item IMPORTANT: PREGABALIN AND...

MHRA RECLASSIFIES VIAGRA CONNECT TABLETS TO A PHARMACY MEDICINE

The Medicines and Healthcare products Regulatory Agency (MHRA) has announced Viagra Connect (containing sildenafil 50mg) will be formally classified from a prescription only medicine (POM) to a pharmacy medicine (P).

https://www.gov.uk/government/consultations/proposal-to-make-sildenafil-50mg-film-coated-tablets-available-from-pharmacies

This means it could be available without prescription for use by men over 18 who have erectile dysfunction.

This decision was made following a reassuring assessment of the safety of the Viagra Connect, advice from the Commission on Human Medicines, and a public consultation earlier this year with positive outcome.

If marketed, the medicine will be sold from pharmacies following a discussion with the pharmacist. Pharmacists will be able to determine whether treatment is appropriate for the patient and can give advice on erectile dysfunction, usage of the medicine, potential side effects, and if further consultation with a general practitioner is required.

Viagra Connect will not be sold to those with severe cardiovascular disorders; at high cardiovascular risk; liver failure; severe kidney failure; or taking certain interacting medicines. Use of Viagra Connect in these groups of men must continue to be under the supervision of a doctor.

Making this medication more widely available will help direct men who might not otherwise seek help into the healthcare system and away from the risks that come with buying medicines from websites operating illegally.